These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
786 related articles for article (PubMed ID: 15085289)
1. Where and when does pancreatic carcinoma start? Lüttges J; Hahn S; Klöppel G Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289 [TBL] [Abstract][Full Text] [Related]
2. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
3. The pathology of ductal-type pancreatic carcinomas and pancreatic intraepithelial neoplasia: insights for clinicians. Klöppel G; Lüttges J Curr Gastroenterol Rep; 2004 Apr; 6(2):111-8. PubMed ID: 15191688 [TBL] [Abstract][Full Text] [Related]
5. Update on the pathology and genetics of exocrine pancreatic tumors with ductal phenotype: precursor lesions and new tumor entities. Lüttges J; Klöppel G Dig Dis; 2001; 19(1):15-23. PubMed ID: 11385247 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
7. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145 [TBL] [Abstract][Full Text] [Related]
9. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions. Recavarren C; Labow DM; Liang J; Zhang L; Wong M; Zhu H; Wang J; Francis F; Xu R Hum Pathol; 2011 Jan; 42(1):18-24. PubMed ID: 21056895 [TBL] [Abstract][Full Text] [Related]
10. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues. Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic intraepithelial neoplasia revisited and updated. Sipos B; Frank S; Gress T; Hahn S; Klöppel G Pancreatology; 2009; 9(1-2):45-54. PubMed ID: 19077454 [TBL] [Abstract][Full Text] [Related]
12. Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter. Suda K; Nobukawa B; Yamasaki S; Abe K; Matsukuma S; Suzuki F J Hepatobiliary Pancreat Surg; 2007; 14(3):283-8. PubMed ID: 17520204 [TBL] [Abstract][Full Text] [Related]
13. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
14. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756 [TBL] [Abstract][Full Text] [Related]
15. The molecular genetics of pancreatic ductal carcinoma. Sohn TA Minerva Chir; 2002 Oct; 57(5):561-74. PubMed ID: 12370658 [TBL] [Abstract][Full Text] [Related]
16. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts. Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136 [TBL] [Abstract][Full Text] [Related]
17. Secretin receptors in normal and diseased human pancreas: marked reduction of receptor binding in ductal neoplasia. Körner M; Hayes GM; Rehmann R; Zimmermann A; Friess H; Miller LJ; Reubi JC Am J Pathol; 2005 Oct; 167(4):959-68. PubMed ID: 16192632 [TBL] [Abstract][Full Text] [Related]
18. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. Wada K J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900 [TBL] [Abstract][Full Text] [Related]